Insight · Buyer's guide
Choosing a PCN pharmacist provider — a checklist for Clinical Directors.
Why this matters.
Picking the wrong pharmacist provider costs PCNs more than money — it costs months of mobilisation, lost ARRS allocation, and damage to GP trust in pharmacist roles. The checklist below is the one we'd use if we were sitting on the buying side of the table.
Frame the decision before you go to market.
Before you contact a single provider, decide internally what the pharmacist role is actually for. Is the primary objective converting ARRS allocation into measurable QOF improvement? Is it absorbing GP workload around prescription queries and discharge reconciliation? Is it running a structured care home review programme? Is it a defensive move because solo recruitment failed twice? These objectives look identical in a job description but produce very different procurement decisions, and the providers that win each one are not the same.
Clinical Directors who skip this framing step almost always end up with a generic pharmacist sessional contract that satisfies no-one. The exercise takes about an hour with your Practice Managers and prescribing lead and it pays back many times over in how confidently you can compare bids.
Governance
Ask for evidence of these.
- Cyber Essentials Certified
- NHS DSPT compliant
- GPhC-registered pharmacists with documented supervision
- Clinical indemnity in place for every role
- DPIA template specific to your contract
- Named QA lead independent of delivery
Capacity & cover
What happens when things go wrong.
- Documented sickness and leave cover from a hub — not 'we'll try to find someone'
- Maternity cover guaranteed
- Replacement guaranteed if a placement doesn't work out
- Evidence of retention vs solo-recruited roles
Supervision
Who actually supervises the pharmacist?
The single biggest difference between a good and a bad ARRS deployment is real clinical supervision. Ask: who supervises the pharmacist, how often, and is it evidenced? If the answer is vague, walk away — ARRS audit will eventually catch it.
- Weekly clinical supervision from a senior pharmacist
- Documented to ARRS standard for audit
- Independent of line management
- Pharmacist has a senior to escalate to in real time
Outcomes
How will you know it's working?
- Monthly outcomes report per PCN
- Outputs tied to IIF and QOF indicators
- Live dashboard access for Clinical Directors
- Defined SLAs for discharge reconciliation, high-risk monitoring, SMRs
- QA sign-off on every report before it leaves
Red flags
Walk away if you hear any of these.
- 'We can't share our governance documentation'
- Pharmacists supervised by their own line manager only
- 'Cover is best efforts'
- No monthly outcomes reporting included
- Generic locum-style day rates billed against ARRS
- Refusal to name the lead pharmacist on your account
What good procurement looks like.
A confident PCN procurement runs in three stages. Stage one: a structured discovery call with two or three shortlisted providers, walking each one through the same set of priorities and asking them to describe how they would actually staff the work. The answers separate service partners from agencies almost immediately.
Stage two: a documented proposal that names the lead pharmacist, the supervisor, the cover plan, the monthly outcomes report, the SLA, the price and the mobilisation date. If a provider cannot put all of that in writing inside two weeks, they are unlikely to deliver consistently in month six.
Stage three: a clear ninety-day review built into the contract. Outcomes against the indicators agreed at procurement, evidence of supervision, evidence of cover events handled, and a frank conversation about what is working and what is not. PCNs that build this into the contract from day one almost never end up trapped in a service that under-delivers.
Talk to our Service Development team
30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.